Company: FTII
Filing Date: 2025-02-14
Form Type: S-4
Source: 0001493152-25-006997
Chunk: 234

Company: FutureTech II Acquisition Corp.
Filing Date: 2025-02-14
Form: S-4
Chunk 234
---
 its search of new Potential Targets and explored six (6) additional Potential Targets.

On June 27, 2024, Mr. Yuquan
Wang (who is the control person of FutureTech Capital, a board member of Cerevast and the proposed Chairman of the Board of FutureTech
following consummation of the Business Combination, and who was the control person of the Sponsor) contacted Mr. Bradford A. Zakes
by phone to propose a potential business combination between FutureTech and Longevity. During the call, Mr. Bradford A. Zakes raised
the question of potential conflict of interest based on the fact that Mr. Yuquan Wang is an investor in and on the board of directors
of Cerevast in addition to being part of the management team and control person of the Sponsor. During the call, Mr. Yuquan Wang
indicated that (i) he was no longer part of the management team of the Sponsor and that this role had been transferred to Mr.
Ray Chen, and that (2) he was no longer the control person of the Sponsor and this role had been transferred to Mr. Zachary Radu.

| 116 |

On June 28, 2024,
Mr. Ray Chen from FutureTech, Mr. Bradford A. Zakes, Ms. Brenda Sparks and representatives of FutureTech Capital met to discuss the potential
of a business combination amongst the parties.

On July 1, 2024,
Mr. Bradford A. Zakes, Ms. Brenda Sparks, and representatives of FutureTech Capital and Nelson Mullins met to discuss and evaluate the
feasibility of moving forward with a potential business combination between FutureTech and Longevity given the potential conflicts of
interest. During the call, Nelson Mullins indicated that because of FutureTech Capital’s association with FutureTech, Nelson Mullins
would not be able to continue representing both FutureTech Capital and Longevity under the proposed business combination. After a discussion,
it was decided that Nelson Mullins would continue to represent Longevity and FutureTech would engage other counsel.

On July 2, 2024,
Mr. Bradford A. Zakes and Mr. Yuquan Wang met and discussed the proposed business combination and agreed to continue to evaluate the proposed
business combination.

On July 3, 2024,
Mr. Ray Chen, Mr. Bradford A. Zakes, Ms. Brenda Sparks, Mr. Ying Shan and Mr. Yuquan Wang met, and Mr. Zakes proposed a valuation of $